PYXS SCHEDULE 13G: SEC filing

OrbiMed Advisors LLC and OrbiMed Capital LLC

Filed with the SEC on · accession 0000947871-26-001035

PYXS filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -8.5% by the first close after the filing.

Summary of the filing

OrbiMed Advisors LLC and OrbiMed Capital LLC filed a Schedule 13G disclosing passive ownership of approximately 7.0% of Pyxis Oncology's common stock in the aggregate, with OrbiMed Advisors holding 3.4% and OrbiMed Capital holding 3.6%.

Key details

Shares beneficially owned by OrbiMed Advisors LLC$4.0M
Shares beneficially owned by OrbiMed Capital LLC$4.3M
IssuerPyxis Oncology, Inc.
Reporting person / beneficial ownerOrbiMed Advisors LLC
Reporting person / beneficial ownerOrbiMed Capital LLC
Member, orbimed advisors llc and orbimed capital llcCarl L. Gordon
Management committee memberW. Carter Neild
Management committee memberGeoffrey C. Hsu

How PYXS stock reacted

Close before

$1.58

Nov 13, 2026

First close after

-8.54%

$1.45

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for PYXS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PYXS?

Click here

Frequently asked questions

What did PYXS file with the SEC on Nov 16, 2026?

PYXS filed a SCHEDULE 13G (SEC filing). OrbiMed Advisors LLC and OrbiMed Capital LLC filed a Schedule 13G disclosing passive ownership of approximately 7.0% of Pyxis Oncology's common stock in the aggregate, with OrbiMed Advisors holding 3.4% and OrbiMed Capital holding 3.6%.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did PYXS stock react to this filing?

PYXS closed at $1.58 before the filing and $1.45 on Nov 16, 2026 (-8.54%).

Other PYXS SEC filings

Get alerts when PYXS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days